159 related articles for article (PubMed ID: 30715229)
1. Testosterone in Men With Chronic Hepatitis C Infection and After Hepatitis C Viral Clearance.
Chaudhury CS; Mee T; Chairez C; McLaughlin M; Silk R; Gross C; Kattakuzhy S; Rosenthal E; Kottilil S; Stanley TL; Hadigan C
Clin Infect Dis; 2019 Aug; 69(4):571-576. PubMed ID: 30715229
[TBL] [Abstract][Full Text] [Related]
2. Impact of Hepatitis C Virus Cure on Depressive Symptoms in the Human Immunodeficiency Virus-Hepatitis C Virus Coinfected Population in Canada.
Marathe G; Moodie EEM; Brouillette MJ; Lanièce Delaunay C; Cox J; Martel-Laferrière V; Gill J; Cooper C; Pick N; Vachon ML; Walmsley S; Klein MB;
Clin Infect Dis; 2023 Feb; 76(3):e702-e709. PubMed ID: 35789253
[TBL] [Abstract][Full Text] [Related]
3. The determination of total testosterone and free testosterone (RIA) are not applicable to the evaluation of gonadal function in HIV-infected males.
Moreno-Pérez O; Escoín C; Serna-Candel C; Portilla J; Boix V; Alfayate R; González-Sánchez V; Mauri M; Sánchez-Payá J; Picó A
J Sex Med; 2010 Aug; 7(8):2873-83. PubMed ID: 20626606
[TBL] [Abstract][Full Text] [Related]
4. Antiviral regimen complexity index as an independent predictor of sustained virologic response in patients with chronic hepatitis C.
Galán RJ; Cidoncha EC; Martin MF; Rodriguez CC; Almeida CV; Verdugo RM
J Manag Care Pharm; 2013; 19(6):448-53. PubMed ID: 23806058
[TBL] [Abstract][Full Text] [Related]
5. Ribavirin Concentrations Do Not Predict Sustained Virological Response in HIV/HCV-Coinfected Patients Treated with Ribavirin and Pegylated Interferon in the Swiss HIV Cohort Study.
Kovari H; Russmann S; Ledergerber B; Müller D; Rotger M; Velli P; Cavassini M; Ambrosioni J; Bregenzer A; Stöckle M; Bernasconi E; Rauch A; Speck RF;
PLoS One; 2015; 10(7):e0133879. PubMed ID: 26218843
[TBL] [Abstract][Full Text] [Related]
6. Risk Factors for Hepatitis C Virus Reinfection After Sustained Virologic Response in Patients Coinfected With HIV.
Young J; Rossi C; Gill J; Walmsley S; Cooper C; Cox J; Martel-Laferriere V; Conway B; Pick N; Vachon ML; Klein MB;
Clin Infect Dis; 2017 May; 64(9):1154-1162. PubMed ID: 28199495
[TBL] [Abstract][Full Text] [Related]
7. Hypogonadism and liver fibrosis in HIV-infected patients.
Quiros-Roldan E; Porcelli T; Pezzaioli LC; Degli Antoni M; Paghera S; Properzi M; Focà E; Carriero C; Castelli F; Ferlin A
J Endocrinol Invest; 2021 Sep; 44(9):1971-1979. PubMed ID: 33515211
[TBL] [Abstract][Full Text] [Related]
8. Rapid decline of anti-hepatitis C virus (HCV) antibodies following early treatment of incident HCV infections in HIV-infected men who have sex with men.
Aebi-Popp K; Wandeler G; Salazar-Vizcaya L; Metzner K; Stöckle M; Cavassini M; Hoffmann M; Lüthi A; Suter F; Bernasconi E; Fehr J; Furrer H; Rauch A;
HIV Med; 2018 Jul; 19(6):420-425. PubMed ID: 29573533
[TBL] [Abstract][Full Text] [Related]
9. Liver Fibrosis in Human Immunodeficiency Virus (HIV)-Hepatitis C Virus (HCV) Coinfection Before and After Sustained Virologic Response: What Is the Best Noninvasive Marker for Monitoring Regression?
Kronfli N; Young J; Wang S; Cox J; Walmsley S; Hull M; Cooper C; Martel-Laferriere V; Wong A; Pick N; Klein MB;
Clin Infect Dis; 2021 Aug; 73(3):468-477. PubMed ID: 32504083
[TBL] [Abstract][Full Text] [Related]
10. The Role of Hepatitis C Virus NS5A Region Mutation and SNP IL-28B of Host to Support Successful Pegylated Interferon and Ribavirin Treatment in Patients with HCV-HIV Coinfection: A Prospective Cohort Study.
Kurniawan J; Gani RA; Djauzi S; Ibrahim F; Harimurti K; Nafrialdi N; Imannuel S
Acta Med Indones; 2019 Apr; 51(2):128-136. PubMed ID: 31383827
[TBL] [Abstract][Full Text] [Related]
11. Chronic hepatitis C infection and sex hormone levels: effect of disease severity and recombinant interferon-alpha therapy.
Nguyen HV; Mollison LC; Taylor TW; Chubb SA; Yeap BB
Intern Med J; 2006 Jun; 36(6):362-6. PubMed ID: 16732861
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C Virus Cure in Human Immunodeficiency Virus Coinfection Dampens Inflammation and Improves Cognition Through Multiple Mechanisms.
Sun B; Abadjian L; Monto A; Freasier H; Pulliam L
J Infect Dis; 2020 Jul; 222(3):396-406. PubMed ID: 32157304
[TBL] [Abstract][Full Text] [Related]
13. The importance of SHBG and calculated free testosterone for the diagnosis of symptomatic hypogonadism in HIV-infected men: a single-centre real-life experience.
Pezzaioli LC; Quiros-Roldan E; Paghera S; Porcelli T; Maffezzoni F; Delbarba A; Degli Antoni M; Cappelli C; Castelli F; Ferlin A
Infection; 2021 Apr; 49(2):295-303. PubMed ID: 33289905
[TBL] [Abstract][Full Text] [Related]
14. Metabolic Changes in Chronic Hepatitis C Patients Who Carry IFNL4-ΔG and Achieve Sustained Virologic Response With Direct-Acting Antiviral Therapy.
Emmanuel B; El-Kamary SS; Magder LS; Stafford KA; Charurat ME; Chairez C; McLaughlin M; Hadigan C; Prokunina-Olsson L; O'Brien TR; Masur H; Kottilil S
J Infect Dis; 2020 Jan; 221(1):102-109. PubMed ID: 31504644
[TBL] [Abstract][Full Text] [Related]
15. Retrospective study of hepatitis C outcomes and treatment in HIV co-infected persons from the Australian HIV Observational Database.
Puhr R; Wright ST; Hoy JF; Templeton DJ; Durier N; Matthews GV; Russell D; Law MG
Sex Health; 2017 Aug; 14(4):345-354. PubMed ID: 28482168
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C Virus (HCV) Direct-Acting Antiviral Therapy in Persons With Human Immunodeficiency Virus-HCV Genotype 1 Coinfection Resulting in High Rate of Sustained Virologic Response and Variable in Normalization of Soluble Markers of Immune Activation.
Anthony DD; Sulkowski MS; Smeaton LM; Damjanovska S; Shive CL; Kowal CM; Cohen DE; Bhattacharya D; Alston-Smith BL; Balagopal A; Wyles DL
J Infect Dis; 2020 Sep; 222(8):1334-1344. PubMed ID: 32406487
[TBL] [Abstract][Full Text] [Related]
17. Relative impact of ribavirin monitoring and HIV coinfection on sustained virological response in patients with chronic hepatitis C.
Piedoux S; Monnet E; Piroth L; Montange D; Royer B; Thevenot T; Kantelip JP; Di Martino V; Muret P;
Antivir Ther; 2011; 16(8):1317-26. PubMed ID: 22155913
[TBL] [Abstract][Full Text] [Related]
18. CD4 and CD4/CD8 ratio progression in HIV-HCV infected patients after achievement of SVR.
Saracino A; Bruno G; Scudeller L; Ladisa N; de Gennaro N; Allegrini M; Monno L; Angarano G
J Clin Virol; 2016 Aug; 81():94-9. PubMed ID: 27371888
[TBL] [Abstract][Full Text] [Related]
19. Human Immunodeficiency Virus (HIV) Infection Is Associated With Lower Risk of Hepatocellular Carcinoma After Sustained Virological Response to Direct-acting Antivirals in Hepatitis C Infected Patients With Advanced Fibrosis.
Corma-Gómez A; Macías J; Lacalle-Remigio JR; Téllez F; Morano L; Rivero A; Serrano M; Ríos MJ; Vera-Méndez FJ; Alados JC; Real LM; Palacios R; Santos IL; Imatz A; Pineda JA;
Clin Infect Dis; 2021 Oct; 73(7):e2109-e2116. PubMed ID: 32766891
[TBL] [Abstract][Full Text] [Related]
20. Liver Stiffness at the Time of Sustained Virological Response Predicts the Clinical Outcome in People Living With Human Immunodeficiency Virus and Hepatitis C Virus With Advanced Fibrosis Treated With Direct-acting Antivirals.
Corma-Gómez A; Macías J; Téllez F; Freyre-Carrillo C; Morano L; Rivero-Juárez A; Ríos MJ; Alados JC; Vera-Méndez FJ; Merchante N; Palacios R; Granados R; Merino D; De Los Santos I; Pineda JA
Clin Infect Dis; 2020 Dec; 71(9):2354-2362. PubMed ID: 31754695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]